rges peptide has been researched along with Lung Injury, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hah, JS; Han, JR; Kang, JL; Moon, C; Park, HJ | 1 |
1 other study(ies) available for rges peptide and Lung Injury, Acute
Article | Year |
---|---|
Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Chemotaxis; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Kinase 1; Inflammation Mediators; Integrin alphaVbeta3; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Lung; Macrophages; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pneumonia; Time Factors; Tumor Necrosis Factor-alpha | 2009 |